News
The latest insights, sector developments and case updates from Potter Clarkson. Explore up-to-date content from our experts and stay informed on the issues shaping the IP landscape.
The latest insights, sector developments and case updates from Potter Clarkson. Explore up-to-date content from our experts and stay informed on the issues shaping the IP landscape.

The UPC Court of Appeal has overturned a decision of the Lisbon Local Division and granted Boehringer Ingelheim (“Boehringer”) a provisional injunction for imminent patent infringement. In doing so, it has confirmed that completion of national pricing and reimbursement procedures for generic drugs may be sufficient to trigger injunctive relief.

We’re proud to announce that Potter Clarkson has once again been recognised in the Chambers UK Guide 2026.
.avif)
Two recent English Court of Appeal decisions show how legally binding agreements may arise in commercial situations despite the apparent absence of the usual contractual requirements.

When you hear “kissing bug,” you might picture something harmless or even endearing. But this insect delivers anything but affection; it transmits Trypanosoma cruzi, the parasite responsible for Chagas disease, a potentially deadly illness affecting millions worldwide.

As 2025 draws to a close, brand owners face an important deadline that could affect their UK trade mark rights. From 1 January 2026, it is no longer possible to rely on evidence of use in the EU to maintain the validity of UK comparable trade marks (often called “Brexit clones”). This marks the end of the grace period for use, originally set out in the UK/EU Withdrawal Agreement.

Potter Clarkson has once again been highly recognised in the 2026 Legal 500 rankings, a leading guide for clients seeking top law firms, attorneys, and solicitors.
.png)
Following its previous widely-reported ruling earlier this year, the Mannheim Local Division has now issued its decision in respect of the UK aspect of the infringement proceedings brought by FujiFilm, marking the first time that the UPC has granted an injunction which applies to the UK.

Space agriculture (or as you may know it, space-based AgTech, astroagriculture, exo-agriculture, off-earth farming or extraterrestrial food systems) refers to agricultural technologies and systems developed or tested in space.

From engineered microbes cleaning up environmental waste to CRISPR-edited cells powering next-generation therapies, synthetic biology is shaping industries, economies, and everyday life.

The SPC manufacturing waiver, introduced in 2019 under Regulation (EU) No 2019/933, marked a pivotal development in EU pharmaceutical law.

Gene editing technologies like CRISPR and RNA interference (RNAi) are revolutionising agriculture.

A Board of Appeal at the EPO has referred questions to the Enlarged Board of Appeal (EBA) in connection with inconsistencies between the claims and description of a European patent vs. those of a European patent application (pre-grant vs. post-grant).
.avif)
In the recent decision Generics v AstraZeneca, the UK Court of Appeal confirmed that the UK’s approach to ‘plausibility’ remains unchanged despite the EPO Enlarged Board of Appeal decision G2/21.
.avif)
In April 2023, the European Commission adopted a comprehensive package of proposed reforms to the legislation governing the authorisation of medicines in the EU.

The revamped UPC Case Management System (‘CMS’) is now live. The objective of the new CMS is to simplify access for users. This will be a welcome update for IP practitioners who have in the past experienced various issues when using the old CMS.
.jpg)
The implementation of the Windsor Framework on 1 January 2025 marked a significant turning point in the UK’s regulatory landscape for human medicines.